Local Institution — Canton, Ohio

Local Institution is a clinical research site located in Canton, Ohio, United States.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution has participated in 10 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus, Non-Small-Cell Lung Carcinoma, Diabetes Mellitus II.

Sponsors: Bristol-Myers Squibb, Eli Lilly and Company, R-Pharm.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Canton

Browse all research sites in Ohio · View every site in Canton

• Aultman Hospital; Aultman Hospital Cancer Center
• Piedmont Hospital, Inc.
• Aultman Hospital Cancer Center at Aultman Health Foundation
• Cleveland Clinic Mercy Hospital
• Aultman Hospital Research
• Aultman Hospital, Cardiovascular Consultants, Inc
• Aultman Hospital Clinical Trials
• Mercy Hospital
• Cleveland Clinic Mercy Hospital Cancer Center
• Medical Oncology Aultman Hospital
• University Hospitals Ireland Cancer Center at Mercy Medical Center
• Aultman Hospital Cancer Center

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution?

Local Institution has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution conducted?

Local Institution has 10 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Non-Small-Cell Lung Carcinoma, Diabetes Mellitus II.

Is Local Institution accredited by Crixeo Clinical Trials?

Local Institution has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.